Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 2/20 | 0.60 |
| ▸ | DRD2 | P14416 | 2/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.43 |
| ▸ | NSD2 | O96028 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 3/20 | 0.41 |
| ▸ | USP30 | Q70CQ3 | 1/20 | 0.41 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.41 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
| ▸ | FFAR2 | O15552 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14632427 | 0.92 | NOTUM (0.57) | NOTUMDRD2DRD3ALOX5MGLL | |
| SCHEMBL6988378 | 0.92 | NOTUM (0.57) | NOTUMDRD2DRD3ALOX5MGLL | |
| SCHEMBL6839819 | 0.91 | NOTUM (0.56) | NOTUMDRD2DRD3ALOX5MGLL | |
| SCHEMBL14632375 | 0.91 | NOTUM (0.56) | NOTUMDRD2DRD3ALOX5MGLL | |
| SCHEMBL6839730 | 0.84 | DRD2 (0.52) | NOTUMDRD2DRD3ALOX5NSD2 | |
| SCHEMBL9891644 | 0.82 | HRH3 (0.46) | NOTUMHRH3FFAR2 | |
| SCHEMBL6989709 | 0.80 | NOTUM (0.50) | NOTUMDRD2DRD3ALOX5NSD2 | |
| SCHEMBL6992302 | 0.80 | NOTUM (0.50) | NOTUMDRD2DRD3ALOX5NSD2 | |
| SCHEMBL7117504 | 0.79 | NOTUM (0.59) | NOTUMDRD2DRD3ALOX5NSD2 | |
| SCHEMBL5702089 | 0.78 | NOTUM (0.49) | NOTUMUSP30 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030176465-A1 | Cyclic amino acid derivatives | MERCK PATENT GMBH (DE) | 2003-09-18 | — | — | US | disclosed |
| EP-1301506-A1 | CYCLIC AMINO ACID DERIVATIVES | MERCK PATENT GmbH (DE) | 2003-04-16 | — | — | EP | disclosed |
| WO-2002006269-A1 | CYCLIC AMINO ACID DERIVATIVES | MERCK PATENT GMBH (DE) | 2002-01-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176465-A1 | Cyclic amino acid derivatives | F5, F11, F2 | NOTUM 4067/4885DRD2 3651/4885DRD3 3576/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.